Primary study · included by 1 review
Double-blind, placebo-controlled, randomized phase II study of TJ-14 (hangeshashinto) for gastric cancer chemotherapy-induced oral mucositis
Aoyama 2014 · Aoyama Toru, Nishikawa Kazuhiro, Takiguchi Nobuhiro, et al. · Cancer Chemotherapy and Pharmacology · 2014
Included by
| Outcome this study informs | Pooled effect | Evidence | Certainty |
|---|---|---|---|
Chemotherapy-induced oral mucositis (grade 2 or higher by CTCAE v5.0, described as more than grade 1) Hangeshashinto (TJ-14) during chemotherapy vs No hangeshashinto or placebo | RR 0.86 [0.73, 1.00] | 6 studies · 293 participants | Moderate |
Chemotherapy-induced oral mucositis (grade 2 or higher by CTCAE v5.0, described as more than grade 1) Hangeshashinto (TJ-14) during chemotherapy vs No hangeshashinto or placebo | RR 0.90 [0.67, 1.21] | 4 studies | GRADE not reported |
Chemotherapy-induced oral mucositis (grade 2 or higher by CTCAE v5.0, described as more than grade 1) Hangeshashinto (TJ-14) during chemotherapy vs No hangeshashinto or placebo | RR 0.81 [0.56, 1.17] | 2 studies | GRADE not reported |
1 including review in total.